48 Participants Needed

Cryoablation for Rib Fractures

CN
Overseen ByCandace Nelson
Age: 18+
Sex: Any
Trial Phase: Phase 4
Sponsor: University of Minnesota
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

Trial Summary

What is the purpose of this trial?

The purpose of this study is to determine if patients with rib fractures who undergo cryoablation of the intercostal nerves have improved pain control 7 days from procedure when compared to those who have a ESP catheter.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Cryoablation for Rib Fractures?

Research shows that cryoablation, when used for rib fractures, can effectively control pain, reduce the need for opioid painkillers, and shorten hospital stays. Patients who received cryoablation reported no chest pain and were not using opiate analgesics at one-month follow-up, indicating its potential to improve recovery and respiratory status.12345

How is cryoablation different from other treatments for rib fractures?

Cryoablation is unique because it involves freezing the intercostal nerves to provide targeted pain relief, which can reduce the need for opioid painkillers and shorten hospital stays. Unlike traditional pain management methods, it offers a more durable solution without the complications associated with rib fixation surgery.12456

Research Team

NH

Neil Hanson

Principal Investigator

University of Minnesota

Eligibility Criteria

This trial is for adults over the age of 18 who have suffered from multiple rib fractures. It's not specified who can't join, but typically those with conditions that might interfere with the treatment or skew results would be excluded.

Inclusion Criteria

I am over 18 and have multiple broken ribs.

Exclusion Criteria

I cannot have regional anesthesia due to a specific reason.
Patients who are pregnant via self-report or positive pregnancy test
Non-English speakers
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo cryoablation of the intercostal nerves or receive an ESP catheter for rib fracture pain management

7 days
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, including pain scores and opioid use

30 days
Multiple assessments (in-person and virtual)

Treatment Details

Interventions

  • Cryoablation
  • ESP Catheter
Trial Overview The study is testing whether cryoablation (freezing) of nerves between ribs offers better pain control after 7 days compared to using an ESP (Erector Spinae Plane) catheter, which delivers local anesthesia near the spine.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: CryoablationExperimental Treatment1 Intervention
Participants with rib fracture randomized to Cryoablation.
Group II: ESP catheterActive Control1 Intervention
Participants with rib fracture randomized to ESP Catheter.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Minnesota

Lead Sponsor

Trials
1,459
Recruited
1,623,000+

Findings from Research

Intercostal nerve cryoablation (IC) during surgical stabilization of rib fractures (SSRF) was found to be safe and feasible, with no significant immediate or long-term complications reported among the 20 patients who underwent the procedure.
While the study did not show a significant reduction in pain scores or opioid use for the SSRF-IC group compared to the SSRF group, further research is needed to fully evaluate the analgesic efficacy of IC for rib fractures.
Intercostal nerve cryoablation during surgical stabilization of rib fractures.Choi, J., Min, JG., Jopling, JK., et al.[2023]
In a case study of 3 trauma patients with rib fractures, video-assisted thoracoscopic cryoablation of intercostal nerves effectively managed pain without causing respiratory complications like pneumonia or atelectasis post-surgery.
At one-month follow-up, all patients reported complete relief from chest pain and did not require opiate analgesics, suggesting that cryoablation can enhance respiratory function and reduce the need for ventilators in patients with unstable rib fractures.
Cryoablation for Chest Wall Trauma: A Brief Report.Farley, P., Buckley, CT., Mullen, PR., et al.[2022]
In a study involving 101 elderly patients with rib fractures, those treated with coolant spray experienced significantly greater pain relief compared to those receiving a placebo, particularly within the first 60 minutes after application.
The results suggest that coolant spray therapy is an effective analgesic option for managing pain in geriatric patients with rib fractures, supporting its use as part of a multimodal pain management strategy.
Effect of coolant spray on rib fracture pain of geriatric blunt thoracic trauma patients: a randomized controlled trial.Akbaş, İ., Dogruyol, S., Kocak, AO., et al.[2023]

References

Intercostal nerve cryoablation during surgical stabilization of rib fractures. [2023]
Cryoablation for Chest Wall Trauma: A Brief Report. [2022]
Effect of coolant spray on rib fracture pain of geriatric blunt thoracic trauma patients: a randomized controlled trial. [2023]
Surgical stabilization of rib fractures combined with intercostal nerve cryoablation proves to be more cost effective by reducing hospital length of stay and narcotics. [2021]
Intercostal nerve cryoablation during surgical stabilization of rib fractures decreases post-operative opioid use, ventilation days, and intensive care days. [2023]
Sclerotic vertebral metastases: pain palliation using percutaneous image-guided cryoablation. [2014]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security